Related Experiment Video
Updated: Aug 24, 2025
04:34
Surgical Treatment of an Endolymphatic Sac Tumor
Published on: May 26, 2023
791
Updates on Sturge-Weber Syndrome
SangEun Yeom1, Anne M Comi1,2,3,4
1Department of Neurology and Developmental Medicine, Hugo Moser Kennedy Krieger Research Institute, Baltimore, MD (S.Y., A.M.C.).
Stroke
|October 20, 2022
Summary
Sturge-Weber syndrome (SWS) is a rare neurovascular disorder affecting the brain, skin, and eyes. Research explores genetic links, including GNAQ mutations, and promising treatments like low-dose aspirin, cannabidiol, and Sirolimus.
Area of Science:
- Neuroscience
- Genetics
- Vascular Biology
Background:
- Sturge-Weber syndrome (SWS) is a rare, non-inherited neurovascular disorder.
- Characterized by abnormal vasculature in the brain, skin, and eye, leading to port-wine birthmarks, leptomeningeal angiomas, and glaucoma.
- Associated with impaired brain perfusion, increasing risks of stroke, seizures, and neurological deficits.
Purpose of the Study:
- To review the latest research advancements in Sturge-Weber syndrome.
- To highlight current and potential future research directions for SWS.
Main Methods:
- Review of recent retrospective studies and prospective drug trials.
- Analysis of genetic research implicating somatic mutations.
- Focus on therapeutic interventions and presymptomatic treatment strategies.
Main Results:
- Identifies R183Q GNAQ somatic mutation as common in SWS; GNA11 and GNB2 mutations also implicated.
- Low-dose aspirin and vitamin D show potential in retrospective studies.
- Cannabidiol and Sirolimus demonstrate usefulness in prospective trials; presymptomatic aspirin and antiepileptics show promise in delaying seizures.
Conclusions:
- Ongoing research is expanding the understanding of SWS genetics and pathophysiology.
- Emerging treatments offer hope for improved management and outcomes in SWS patients.
- Future research should focus on validating these treatments and exploring novel therapeutic targets.
Related Concept Videos
01:22Mitral Stenosis I: Introduction
27
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
27
01:24Cystic Fibrosis: Management
213
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
213
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests
29
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
29
01:21Barrett Esophagus-II: Clinical Manifestations and Management
266
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
266
01:26Mitral Stenosis III: Medical Management
16
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
16
01:21Aneurysm II: Clinical Manifestations and Diagnostic Studies
19
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
19